BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19941919)

  • 1. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.
    Gunaseelan S; Gunaseelan K; Deshmukh M; Zhang X; Sinko PJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):518-31. PubMed ID: 19941919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic Delivery of Anti-HIV Drug Nanoparticles.
    Nayak Y; Avadhani K; Mutalik S; Nayak UY
    Recent Pat Nanotechnol; 2016; 10(2):116-27. PubMed ID: 27502389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in antiretroviral drug delivery using nanotechnology.
    Mallipeddi R; Rohan LC
    Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
    Khan T; Mayuresh Patkar M; Momin M; Omri A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
    Gao Y; Kraft JC; Yu D; Ho RJY
    Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.
    Heon Lee I; Palombo MS; Zhang X; Szekely Z; Sinko PJ
    Eur J Pharm Biopharm; 2019 May; 138():11-22. PubMed ID: 29894816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimers as nanocarriers for nucleoside analogues.
    Gorzkiewicz M; Klajnert-Maculewicz B
    Eur J Pharm Biopharm; 2017 May; 114():43-56. PubMed ID: 28089915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.
    Edagwa BJ; Zhou T; McMillan JM; Liu XM; Gendelman HE
    Curr Med Chem; 2014; 21(36):4186-98. PubMed ID: 25174930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection.
    Désormeaux A; Bergeron MG
    J Drug Target; 1998; 6(1):1-15. PubMed ID: 9769017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
    Din FU; Aman W; Ullah I; Qureshi OS; Mustapha O; Shafique S; Zeb A
    Int J Nanomedicine; 2017; 12():7291-7309. PubMed ID: 29042776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
    Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
    Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated nanocarriers: A promising tool for targeted delivery to the brain.
    Gajbhiye KR; Pawar A; Mahadik KR; Gajbhiye V
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110770. PubMed ID: 31926790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active targeted drug delivery for microbes using nano-carriers.
    Lin YS; Lee MY; Yang CH; Huang KS
    Curr Top Med Chem; 2015; 15(15):1525-31. PubMed ID: 25877093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted drug delivery to macrophages.
    Jain NK; Mishra V; Mehra NK
    Expert Opin Drug Deliv; 2013 Mar; 10(3):353-67. PubMed ID: 23289618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-Mimicking Polymer Nanoparticles Targeting CD169
    Eshaghi B; Fofana J; Nodder SB; Gummuluru S; Reinhard BM
    ACS Appl Mater Interfaces; 2022 Jan; 14(2):2488-2500. PubMed ID: 34995059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.